相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
The RTS,S vaccine candidate for malaria
Jason A. Regules et al.
EXPERT REVIEW OF VACCINES (2011)
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host
Alida Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial
Pedro Aide et al.
PLOS ONE (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
Caterina Guinovart et al.
PLOS ONE (2009)
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax
Brian A. Bell et al.
VACCINE (2009)
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
Silayuv E. Bongfen et al.
VACCINE (2009)
Kinetics of Mosquito-Injected Plasmodium Sporozoites in Mice: Fewer Sporozoites Are Injected into Sporozoite-Immunized Mice
Chahnaz Kebaier et al.
PLOS PATHOGENS (2009)
Phylogeny.fr: robust phylogenetic analysis for the non-specialist
A. Dereeper et al.
NUCLEIC ACIDS RESEARCH (2008)
Class II-restricted protective immunity induced by malaria sporozoites
Giane A. Oliveira et al.
INFECTION AND IMMUNITY (2008)
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
Anjali Yadava et al.
INFECTION AND IMMUNITY (2007)
An update on the search for a Plasmodium vivax vaccine
Socrates Herrera et al.
TRENDS IN PARASITOLOGY (2007)
Modeling a field trial of the RTS,S/AS02A malaria vaccine
Nicolas Maire et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion
D Rathore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
P Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion
A Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes
JP Vanderberg et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein - Significance for malarial sporozoite attachment to hepatocytes
JB Ancsin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
A Takada et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
分享论文
